Inclusion Criteria:  Myopic children (-0.75 to -5.0 D SER, least myopic meridian -0.50 D in each eye) At least BCVA 0.2 LogMAR in each eye Age: 6 - 14 years old Evidence of myopia progression over the preceding year (≤ -0.25 D /year at least) Good tolerability of test session with VR system Binocular adequacy as tested with VR Ability to understand treatment and give valid assent  Exclusion Criteria:  Concomitant or previous therapies for myopia Eye diseases/conditions: Anisometropia ≥ 1.5 D Astigmatism ≥ 3 D Ophthalmological comorbidities Optic nerve abnormalities Suspicion of syndromic or monogenetic myopia Systemic illnesses affecting eye health, eye growth, and/or refraction Any illnesses affecting dopamine function (e.g., sleep disorder) Medication affecting dopamine function, accommodation, pupil size, or having an impact on the ocular surface (such as allergy medications) Participation in other clinical studies Medical history (or family history) of photosensitive epilepsy